此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

通过利多卡因研究,ESP与ITP块之后的分散体 (DEVILS)

2026年10月26日 更新者:Duke University

勃起脊柱平面块与横向跨过程块:健康志愿者的随机对照试验

Regional anesthesia techniques (or nerve blocks) are used to provide sensory blockade over the chest wall. The most established technique is thoracic epidural. This provides bilateral spread but is also associated with neuraxial complications, which has led to a decrease in clinical usage. Alternative peripheral nerve block techniques, such as intercostal nerve blocks, eliminate the neuraxial complications but, in turn, require numerous injections to provide unilateral coverage. The introduction of ultrasound-guided (USG) nerve blocks has generated clinical interest in the development of novel paraspinal (non-epidural) nerve block techniques, which will provide multiple dermatomal coverage with a single injection. Two such techniques are the Erector Spinae Plane (ESP) block and the Intertransverse Process (ITP) block. The Intertransverse Process (ITP) block targets a slightly deeper plane than the Erector Spinae Plane (ESP) block and was specifically designed to address the ESP block's variable anesthetic spread. Despite its potential for more localized and precise dermatomal coverage, no prior studies have directly compared the two techniques in terms of their cutaneous distribution.

研究概览

详细说明

To compare the dermatomal sensory block distribution, the investigators will use detailed mapping with pinprick, cold, and heat stimuli. The investigators expect similar systemic absorption, the chances of local anesthetic systemic toxicity (LAST) should be equally low, and both blocks should be similarly safe. A total of 14-18 healthy adult volunteers will be included. There will be two different procedure days, separated by at least one week. On each day, the subjects will receive a paraspinal block. Each volunteer will undergo pre-procedure screening on the first visit. The blocks will be performed on the same side, at the same level, by the same anesthesiologist, at least one week apart. An ultrasound-guided ESP block will be administered in one day, and an ITP block on the other. Sensory testing will be performed at baseline and 60-90 minutes after the block injections. Serial samples of blood will be drawn to analyze lidocaine PK (between 0 and 240 minutes post-block).

研究类型

介入性

注册 (实际的)

13

阶段

  • 第四阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • North Carolina
      • Durham、North Carolina、美国、27701
        • Duke University Medical Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Ability to provide written informed consent
  • Ability and willingness to comply with the study procedures and duration requirements
  • ASA physical status 1 or 2
  • Age ≥ 18 years

Exclusion Criteria:

  • BMI > 35kg.m2
  • Use of analgesics within 24 hours before the procedure
  • History of thoracic trauma or surgery
  • Thoracic deformities or abnormalities that may prevent proper block performance
  • Thoracic tattoos
  • Systemic neuromuscular disease
  • Contraindications to regional anesthesia (e.g., infection, allergy, challenging sonoanatomy)
  • Other known health conditions that would affect the participant's ability to successfully complete the study

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:其他
  • 分配:随机化
  • 介入模型:交叉作业
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
有源比较器:Erector Spinae Plane (ESP) Block

Participants receive ESP Block under ultrasound guidance, with 20mL of 1.5% Lidocaine on one visit.

The ESP block will be performed by advancing the needle to the transverse process, under ultrasound guidance, with local anesthetic injected between the erector spinae muscle and the transverse process, targeting a caudad-cephalad spread.

local anesthetic to be used in either the ITP and ESP block

实验性的:Intertransverse Process Block (ITP) Block

Participants receive ITP Block under ultrasound guidance, with 20mL of 1.5% Lidocaine on the other visit.

local anesthetic to be used in either the ITP and ESP block

For the ITP block, the needle will be advanced further into the intertransverse tissue complex between the T4 and T5 transverse processes, and local anesthetic will be injected just above the superior costotransverse ligament, under ultrasound guidance.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Temperature Discrimination
大体时间:60 to 90 minutes post each intervention (interventions occurred 7 days apart)

Skin temperature assessment using gloved ice on the chest wall, to discriminate blocked vs unblocked. Reported as the blocked area in cm^2.

60 to 90 minutes post each intervention (interventions occurred 7 days apart)
Mechanical Discrimination
大体时间:60 to 90 minutes post each intervention (interventions occurred 7 days apart)

Mechanical assessment using a neuropin (pinprick) on the chest wall, to discriminate blocked vs unblocked. Reported as the blocked area in cm^2.

60 to 90 minutes post each intervention (interventions occurred 7 days apart)

次要结果测量

结果测量
措施说明
大体时间
Thermography
大体时间:60 to 90 minutes post each intervention (interventions occurred 7 days apart)

Infrared camera will assess skin temperature of the chest wall.

60 to 90 minutes post each intervention (interventions occurred 7 days apart)
Nociceptive Discrimination
大体时间:60 to 90 minutes post each intervention (interventions occurred 7 days apart)

Nociceptive stimuli will be delivered using controlled heat to discriminate blocked versus unblocked areas on the chest wall.

60 to 90 minutes post each intervention (interventions occurred 7 days apart)

其他结果措施

结果测量
大体时间
Number of Participants With Adverse Events
大体时间:2 days post each block, up to 9 days
2 days post each block, up to 9 days

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Brian Mendelson, MD、Duke University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年6月10日

初级完成 (实际的)

2025年7月26日

研究完成 (实际的)

2025年8月1日

研究注册日期

首次提交

2025年2月20日

首先提交符合 QC 标准的

2025年2月20日

首次发布 (实际的)

2025年2月24日

研究记录更新

最后更新发布 (实际的)

2026年11月17日

上次提交的符合 QC 标准的更新

2026年10月26日

最后验证

2026年10月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

是的

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅